Johnson & Johnson (FRA:JNJ)
Germany
· Delayed Price · Currency is EUR 135.92
+0.82 (0.61%)
Last updated: May 20, 2025
Revenue by Product
Fiscal year is January - December.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2012 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 30, 2025 | Dec '24 Dec 29, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 2, 2022 | 2012 - 2020 |
| Consumer Health | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Consumer Health Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Innovative Medicine | 57.28B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Innovative Medicine Growth | 4.31% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| MedTech | 32.06B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| MedTech Growth | 4.28% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Capex by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2011 - 2019 |
|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 29, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 2, 2022 | 2011 - 2019 |
| Innovative Medicine Capital Expenditures |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Innovative Medicine Capital Expenditures Growth |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| MedTech Capital Expenditures |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| MedTech Capital Expenditures Growth |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2012 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 30, 2025 | Dec '24 Dec 29, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 2, 2022 | 2012 - 2020 |
| United States | 50.99B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| United States Growth | 7.84% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Europe | 20.16B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Europe Growth | 0.88% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Western Hemisphere ex-US | 4.69B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Western Hemisphere ex-US Growth | 0.43% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Asia Pacific, Africa | 13.50B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Asia Pacific, Africa Growth | -1.59% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other
Fiscal year is January - December.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2012 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 30, 2025 | Dec '24 Dec 29, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 2, 2022 | 2012 - 2020 |
| Innovative Medicine Income Before Tax | 19.16B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Innovative Medicine Income Before Tax Growth | 4.85% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| MedTech Income Before Tax | 3.64B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| MedTech Income Before Tax Growth | -6.51% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Sales % Change due to Transactions | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Sales % Change due to Transactions Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Sales % Change due to Price | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Sales % Change due to Price Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Sales % Change due to Currency | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Sales % Change due to Currency Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|